These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 12077578

  • 1. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS, Bagheri S, Nichols K, PUVA Follow Up Study.
    J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
    [Abstract] [Full Text] [Related]

  • 2. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS, Liebman EJ, Väkevä L.
    J Natl Cancer Inst; 1998 Sep 02; 90(17):1278-84. PubMed ID: 9731734
    [Abstract] [Full Text] [Related]

  • 3. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS.
    Blood Cells; 1992 Sep 02; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA, Marcil I, Stern RS.
    J Invest Dermatol; 2002 Jun 02; 118(6):1038-43. PubMed ID: 12060400
    [Abstract] [Full Text] [Related]

  • 6. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
    Lim JL, Stern RS.
    J Invest Dermatol; 2005 Mar 02; 124(3):505-13. PubMed ID: 15737190
    [Abstract] [Full Text] [Related]

  • 7. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
    Kreimer-Erlacher H, Seidl H, Bäck B, Cerroni L, Kerl H, Wolf P.
    J Invest Dermatol; 2003 Apr 02; 120(4):676-82. PubMed ID: 12648234
    [Abstract] [Full Text] [Related]

  • 8. PUVA and skin cancer. A historical cohort study on 492 patients.
    Chuang TY, Heinrich LA, Schultz MD, Reizner GT, Kumm RC, Cripps DJ.
    J Am Acad Dermatol; 1992 Feb 02; 26(2 Pt 1):173-7. PubMed ID: 1552048
    [Abstract] [Full Text] [Related]

  • 9. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL.
    N Engl J Med; 1984 May 03; 310(18):1156-61. PubMed ID: 6709010
    [Abstract] [Full Text] [Related]

  • 10. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS, PUVA Follow-Up Study.
    J Am Acad Dermatol; 2012 Apr 03; 66(4):553-62. PubMed ID: 22264671
    [Abstract] [Full Text] [Related]

  • 11. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H, Kreimer-Erlacher H, Bäck B, Soyer HP, Höfler G, Kerl H, Wolf P.
    J Invest Dermatol; 2001 Aug 03; 117(2):365-70. PubMed ID: 11511317
    [Abstract] [Full Text] [Related]

  • 12. PUVA and cancer risk: the Swedish follow-up study.
    Lindelöf B, Sigurgeirsson B, Tegner E, Larkö O, Johannesson A, Berne B, Ljunggren B, Andersson T, Molin L, Nylander-Lundqvist E, Emtestam L.
    Br J Dermatol; 1999 Jul 03; 141(1):108-12. PubMed ID: 10417523
    [Abstract] [Full Text] [Related]

  • 13. Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998.
    Aubin F, Puzenat E, Arveux P, Louvat P, Quencez E, Humbert P.
    Br J Dermatol; 2001 Jun 03; 144(6):1204-6. PubMed ID: 11422042
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS, Nichols KT, Väkevä LH.
    N Engl J Med; 1997 Apr 10; 336(15):1041-5. PubMed ID: 9091799
    [Abstract] [Full Text] [Related]

  • 16. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
    Takashima A, Matsunami E, Yamamoto K, Kitajima S, Mizuno N.
    Photodermatol Photoimmunol Photomed; 1990 Oct 10; 7(5):218-21. PubMed ID: 2091746
    [Abstract] [Full Text] [Related]

  • 17. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
    Stern RS, Lunder EJ.
    Arch Dermatol; 1998 Dec 10; 134(12):1582-5. PubMed ID: 9875197
    [Abstract] [Full Text] [Related]

  • 18. Genital squamous-cell carcinoma after PUVA therapy.
    de la Brassinne M, Richert B.
    Dermatology; 1992 Dec 10; 185(4):316-8. PubMed ID: 1477434
    [Abstract] [Full Text] [Related]

  • 19. Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis.
    Henseler T, Christophers E, Hönigsmann H, Wolff K.
    J Am Acad Dermatol; 1987 Jan 10; 16(1 Pt 1):108-16. PubMed ID: 3805379
    [Abstract] [Full Text] [Related]

  • 20. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
    Nijsten TE, Stern RS.
    J Invest Dermatol; 2003 Aug 10; 121(2):252-8. PubMed ID: 12880415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.